DiaMedica Therapeutics (DMAC) Inventory Average (2023)
DiaMedica Therapeutics' (DMAC) quarterly Inventory Average came in at $516000.0 in Q4 2023, up 33.33% quarter-over-quarter from $387000.0 in Q3 2023.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Inventory Average (2023) Analysis & Trends
DiaMedica Therapeutics (DMAC) has reported Inventory Average for 1 consecutive years, with $516000.0 the latest figure, recorded in Q4 2023.
- For the quarter ending Q4 2023, Inventory Average changed N/A year-over-year to $516000.0; the trailing twelve-month figure through Dec 2023 stood at $516000.0 (changed N/A YoY), and the FY2023 full-year result was $179500.0, up 131.61% from the prior year.
- Inventory Average climbed to $516000.0 in Q4 2023 per DMAC's latest filing, from $387000.0 in the prior quarter.
- Across five years, Inventory Average topped out at $516000.0 in Q4 2023 and bottomed at $67000.0 in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.17 Bn | 193.18 Bn | 7.24 Bn | 6.20 Bn |
| 2 | Gilead Sciences | 179.52 Bn | 176.34 Bn | 6.22 Bn | 1.93 Bn |
| 3 | Vertex Pharmaceuticals | 131.47 Bn | 123.62 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 81.73 Bn | 73.74 Bn | 3.93 Bn | 3.09 Bn |
| 5 | Argenx Se | 61.16 Bn | 55.98 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.28 Bn | 48.14 Bn | 52.00 Mn | 213.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.06 Bn | 29.76 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Biogen | 31.65 Bn | 30.37 Bn | 1.96 Bn | 2.17 Bn |
| 9 | Roivant Sciences | 29.30 Bn | 29.30 Bn | 1.16 Mn | - |
| 10 | DiaMedica Therapeutics | 346.54 Mn | 346.54 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 516,000.00 |
| Sep 30, 2023 | 387,000.00 |
| Jun 30, 2023 | 75,500.00 |
| Mar 31, 2023 | 67,000.00 |